optimisation of in vitro standard testing of e-vapour and ... · oecd - s. typhimurium strains with...
TRANSCRIPT
Optimisation of in vitro standard
testing of E-Vapour and Heated
Tobacco Products
Roman Wieczorek, Edgar Trelles Sticken
2015 CORESTA Joint Study Groups Meeting
Jeju Island, South Korea, 4-8 October
- ST44 -
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Objective
2
How to optimise existing in vitro methods for testing of
– Smoked Tobacco Products
– Heated Tobacco Products (HTP)
– Electronic Vapour Products (EVP)
The use of accepted and adapted in vitro methods is still the
key to demonstrate the reduced in vitro toxicity of such products
Due to the low toxicity of vapour produced by EVPs the
sensitivity of in vitro test systems towards gas components is of
crucial importance and their effects must be recognised
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Experimental Methods
3
Organisms
Ames - Salmonella typhimurium OECD strains (TA98, TA100, TA102, TA1535 and TA1537)
NRU - Hep-G2 (human liver) for aerosol exposure, TPM and non tobacco materials (NTM)
IVM - V79 (hamster lung) for aerosol exposure
- TK6 (human lymphoblast) for condensates and NTMs
CM7 - CORESTA Monitor Test Piece 7 11-12 puffs
DBC - Dark Blended Cigarette 8-9 puffs
HTP1 - Heated Tobacco Product 1 10 puffs
HTP2 - Heated Tobacco Product 2 10 puffs
EVP - Electronic Vapour Product up to 300 puffs
Products (commercially available)
Smoking regimen 2 puffs per minute / 55 ml puff volumes
• Tobacco products: 2 second puff duration (bell shape)
• EVP: 3 second puff duration (square wave)
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Optimised Exposure in Ames Test
Experimental setup:
Bacteria suspension – per test 120 ml of overnight
cultures are centrifuged and re-suspended in 12 ml PBS to
obtain increased cell densities
Concentrated bacteria suspension (microsuspension assay)
enhance the sensitivity to mutagenic compounds and
concurrently reduces toxic effects of the test aerosol
The fresh aerosol is directed through bacteria suspension
in a glass tube placed in an impinger. After treatment the
bacteria are incubated in the presence and absence of
external metabolic activation system S9
4
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
OECD - S. typhimurium strains with aerosol
The Salmonella microsuspension test with TA100 in ITG-Biolab is a common
procedure for testing of aerosol mutagenicity.
This method is validated and accredited according to ISO17025.
Reproducibility in 9 independent replicates was determined between 16 - 26%
CM7 was used for Whole Smoke and GVP
Vapour generated by EVP from formaldehyde spiked liquid (1%) was used as positive control for Whole Vapour and its GVP
(The formaldehyde concentration in the vapour positive control is significantly higher than detected sometimes in EVPs)
5
TA98 TA100* TA102* TA1535 TA1537
Whole Smoke/Vapour + + + - -
Gas Vapour Phase weak + - - -
OECD recommended S. typhimurium strains were tested for their
response to fresh generated smoke / formaldehyde vapour.
* Formaldehyde as mutagenic aldehyde in Ames test was described in: D. Dillon et al. The effectiveness of Salmonella strains TA100,
TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides; Mutagenesis vol13 no. 1 pp. 19-26, 1998
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Fresh aerosol mutagenicity with TA100
6
HTP2 was less mutagenic than whole smoke of CM7 but similar to the DBC.
HTP1 showed much less mutagenic effects.
However, the vapour of EVP did not show any mutagenic response.
The mutagenic response with aerosol from HTP1 was detected with S. typhimurium
TA100 and TA102 as well.
Positive control for vapour testing
Assays with vapour containing formaldehyde confirm the high sensitivity of
the Salmonella microsuspension Ames test to whole vapour and its gas
phase as well.
The gaseous formaldehyde represents about 60% of mutagenicity of whole
vapour.
CM7
DBC
HTP1
HTP2
EVP
1 0 0 2 0 0
0
5 0
1 0 0
1 5 0
2 0 0
2 5 0
9 0 0 1 0 0 0 1 1 0 0 1 2 0 0
p u ff n u m b e r
re
ve
rta
nts
/p
late
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Demands for optimised cytotoxicological
testing using NRU assay
Due to the modified composition of particulate matter
especially from EVPs, the standard test procedure for
condensate testing is of only limited suitability
Direct exposure of cells to the freshly generated
smoke/aerosol at air liquid interface (ALI) seems to be the
most practicable alternative approach
The sensitivity of in vitro test systems towards gas phase
components is of crucial importance
Cell exposure method in 96 multiwell plate has to be adapted
for a long term treatment (up to 120 minutes)
7
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
View from above
Side view on well with collagen and HepG2 cells
NRU – prolonged ALI exposure in 96 well plate
Organotypic matrix in form of Collagen-I is a proven material for
maintenance of cells under optimal conditions and enables
prolonged exposure to aerosol under ALI conditions.
8
Collagen-I layer (0.1%)
Round bottom of 96 well
Neutral red stained HepG2 cells
on top of Collagen-I surface
HepG2 cells on a Collagen-I matrix are exposed
to aerosol under ALI conditions in a newly
constructed smoke exposure machine (SEIVS).
Multiwell plate with
round bottom wells
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Smoke Exposure In Vitro System (SEIVS)(assembled by Burghart TABAKTECHNIK)
24 well Aerosol Distribution Device
96 well Aerosol Distribution Device
Smoking pumps 1-5
Mixing
pump
Exposure
chamber 1
Exposure
chamber 2
Diluting
pump 1
Diluting
pump 2
2 exposure chambers with separate dilution systems allow
parallel exposure to the same aerosol e.g.
- Whole smoke and GVP
- Different dilution levels per each plate
- Using 24 and 96 multiwell plates
- Suitable for different in vitro assays at a time
Smoke flow through the SEIVS
Puff dependent exposure by covering of wells
Each pump can be used for separate dilution of aerosol
SEIVS - Top view on the exposure chambers and pump units
Cambridge filter
(optional)
9
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Results from parallel exposure WS/WV & GVP
10
HepG2 cells were incubated for 67 hours after exposure
Total cytotoxicity and the contribution
of GVP to Whole aerosol cytotoxicity
Reciprocal EC50 (log) of whole smoke/vapour from selected tobacco products
0,001 0,01 0,1 1 10
DBC
CM7
HTP1
EVP
1/EC50 (log puff number)
Higher 1/EC50 higher Toxicity
Cytotoxicity of WS and GVP
from HTP1
Curve progressions of whole smoke and their GVP
generated from the same smoking runs
30% GVP/WV
19% GVP/WS
9% GVP/WS
16% GVP/WS
0 2 0 4 0 6 0
0
2 0
4 0
6 0
8 0
1 0 0
W S
G V P
p u ff n u m b e r
% c
yto
tox
icit
y
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Fresh aerosol cytotoxicity
11
• The whole smoke of CM7 and dark blend cigarette is more cytotoxic in
comparison to the tested HTP1.
1 hour of exposure
HepG2 cells puffed with ambient air for about 2.5 hours showed similar toxicity to EVP.
EC50
- 0.71
- 0.41
- 9.75
- 128.9
CM7
DBC
HTP1
EVP
0 5 1 0 1 5 2 0
0
2 0
4 0
6 0
8 0
1 0 0
5 0 1 0 0 1 5 0 2 0 0
p u ff n u m b e r
% c
yto
tox
icit
y
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Genotoxicological examination
with V79 cells
Exposure of V79 cells in the IVM assays for
genotoxicity testing is performed using the
SEIVS machine
The cells in IVM assays exposed to the
freshly generated smoke/aerosol at air
liquid interface (ALI) in inserts are placed in
a 24 multiwell plate
After exposure the cells are incubated over
3.5 hours in the presence of S9 following
post-incubation over 22 hours
12
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Effect of whole aerosol and GVP
generated by the same run with V79 cells
13
5 1 0 1 5 2 0
0 .0
0 .2
0 .4
0 .6
p u ff n u m b e r
inc
rea
se
of
MN
W S
G V P
0 5 1 0 1 5 2 0
0 .0
0 .2
0 .4
p u ff n u m b e r
inc
rea
se
of
MN
(%
)
The evaluation method is validated and
accredited according to ISO17025.
Reproducibility in 9 independent replicates for smoke
of CM7 was determined at 25.5%
Whole Smoke and GVP of HTP1 Whole vapour and GVP of formaldehyde spiked liquid (1%)
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Fresh aerosol genotoxicity with V79 cells
14
• The whole smoke of CM7 is more genotoxic in comparison to the tested HTP1.
• EVP did not show any mutagenic response.
* EC-MN is the number of puffs which
results in 3-fold increase against
background level of micronuclei
CM7
HTP1
EVP
EC-MN*
- 0.20
- 9.65
- not determinable
3-fold increase of MN
against background level**
0 5 1 0 1 5 2 0
0 .0
0 .2
0 .4
0 .6
5 0 1 0 0 1 5 0
p u ff n u m b e r
inc
rea
se
of
MN
(%
)
**Expert Opin. Drug Metab. Toxicol. (2011) 7(12):1513-1520
Ewald Roemer et al. Toxicol Mech Methods. 2015 May 19:1-14
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
In Vitro Micronucleus assay with TK6
p53-competent human B lymphoblastoid cell line TK6 is introduced as a
“better predictive” alternative to V79 hamster cells in the IVM assay *
Condensate of test piece CM7 induces dose dependent increases of
micronuclei with and without S9
15
Phase
contrastDAPI
Higher toxicity than 50% (RICC) lead to a
decrease of cells with MN and an increase of
cells with apoptotic morphology
TPM from CM7 test piece shows positive
effects. However, for comparative studies
between different TPMs the dose levels will
need fine adjustment to meet pre-apoptotic
toxicity levels
Further information are presented at STPOST 14
Apoptotic
TK6 cell
* J. Whitwell et al. / Mutation Research 789-790 (2015) 7–27
Tox induced decrease in the
number of MN cells. High
abundance of apoptotic cells.
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A
Conclusions
In order to be able to determine the in vitro toxicity of tobacco smoke and vapour
products the NRU assay, Ames test and IVM assay were optimised:
Positive vapour control for fresh aerosol in vitro testing is developed and
implemented
Ames test procedure is optimised for smoke/vapour and their gas phase components
in particular
In the NRU assay the HepG2 cells are seeded on a collagen-I matrix for prolonged
exposure to aerosol under ALI conditions
Additionally p53-competent human B lymphoblastoid cell line TK6 is introduced for
TPM testing as an alternative to V79 hamster cells in the IVM assay
In NRU and IVM assay a new constructed smoke exposure machine (SEIVS) allows
parallel testing of whole aerosols and their gas phase
16
www.imperialtobaccoscience.com/
2015
_ST
44_W
iecz
orek
SS
PT
2015
- D
ocum
ent n
ot p
eer-
revi
ewed
by
CO
RE
ST
A